This article presents published data and results from our own studies of the use of positron emission tomography (PET) with different radiotracers in multiple sclerosis (MS). Information on the principles of PET is given and grounds are presented for performing PET studies with different radiopharmaceuticals. PET investigation results obtained in MS with different courses are presented, including investigations to identify the locations of neuron damage in the cortical gray matter, to assess microglial activation, and to study the link between glucose metabolism in the brain and the severity of cognitive impairment in MS, yielding new data on the pathogenesis and mechanisms of development of the disease.
Similar content being viewed by others
References
A. Minneboo, B. Jasperse, F. Barkhof, et al., “Measurement of cerebral atrophy has added value in predicting development of disability in early multiple sclerosis,” Mult. Scler., 12, No. 1, 179 (2006).
S. C. Huang, M. E. Phelps, E. J. Hoffman, et al., “Noninvasive determination of local cerebral metabolic rate of glucose in man,” Am J. Physiol., 238, No. 1, 69–82 (1980).
S. V. Medvedev, T. Yu. Skvortsova, and R. N. Krasikova, PET in Russia. Positron Emission Tomography in Clinical Practice and Physiology, Astrel’, St. Petersburg (2008).
M. A. Rocca, B. Colombo, A. Falini, et al., “Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes,” Lancet Neurol., 4, 618–626 (2005).
L. Airas, A. Dickens, M. Haaparanta-Solin, et al., “In vivo positron emission tomography imaging demonstrates diminished microglial activation after FTY720 treatment in an animal model of multiple sclerosis,” Mult. Scler., 19, No. 1, 371 (2013).
B. Bodini, M. Veronese, D. Garcia-Lorenzo, et al., “Positron emission tomography with [11C]-PIB: a clinically relevant tool for voxel-wise myelin quantification in multiple sclerosis,” Mult. Scler., 19, No. 1, 451 (2013).
J. Orgeval, D. Mariano Goulart, L. Collombier, et al., “Contribution of fluorodeoxyglucose positron emission tomography (FDG-PET) in myelitis: a multicentre cohort of 13 cases.,” Mult. Scler., 19, No. 1, 408–409 (2013).
T. Soulier, D. García-Lorenzo, and B. Bodini, “Neuronal damage in cortical lesions: a PET study with [11C]-flumazenil in early relapsing multiple sclerosis,” Mult. Scler., 19, No. 1, 930:423 (2013).
L. Freeman et al., Mult. Scler., 19, No. 11, 205 (2013), doi: 10.1177/1352458513502433.
E. Herranz, C. Gianni, C. Louapre, et al., “11C-PBR28 MR-PET imaging detects in vivo diffuse inflammation in cortex, deep gray and normal appearing white matter associated with neurodegeneration and clinical disability,” Mult. Scler., 23, No. 11, 29–30 (2015).
E. Rissanen, J. M. Tuisku, M. Gardberg, et al., “Microglial activation correlates with disease progression in multiple sclerosis,” Mult. Scler., 23, No. 11, 46–47 (2015).
L. N. Prakhova et al., “Atrophic changes in the brain and their link with neurological impairments in patients with multiple sclerosis,” Zh. Nevrol. Psikhiat., 109, No. 7, 32–37 (2009).
G. V. Kataeva, A. D. Korotkov, and K. V. Mel’nichuk, “Patterns of relative evaluations of regional blood flow and rates of glucose metabolism in the healthy human brain,” Medits. Vizualizats., No. 2, 84–92 (2007).
J. Talairach and P. Tournoux, Co-Planar Stereotactic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging, Thieme, New York (1988).
K. K. Mineev et al., “Relationship between cognitive impairments and focal and atrophic lesions to the brain in multiple sclerosis,” Vestn. Ross. Voenno-Med. Akad., 4, No. 28, 116–120 (2009).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 116, No. 2, Iss. 2, Multiple Sclerosis, pp. 27–31, February, 2016.
Rights and permissions
About this article
Cite this article
Stolyarov, I.D., Petrov, A.M., Shkil’nyuk, G.G. et al. Potential of Positron Emission Tomography for Studies of the Mechanisms of Development of Multiple Sclerosis (published data and authors’ results). Neurosci Behav Physi 47, 540–543 (2017). https://doi.org/10.1007/s11055-017-0432-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-017-0432-0